Doximity Inc
NYSE:DOCS

Watchlist Manager
Doximity Inc Logo
Doximity Inc
NYSE:DOCS
Watchlist
Price: 57.04 USD -1.37%
Market Cap: 10.6B USD
Have any thoughts about
Doximity Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one DOCS stock under the Base Case scenario is 29.6 USD. Compared to the current market price of 57.04 USD, Doximity Inc is Overvalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DOCS Relative Value
Base Case
29.6 USD
Overvaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

20.9
P/S
P/S
Price to Sales
20.9
vs History
27
vs Industry
12
Median 3Y
15.5
Median 5Y
15.7
Industry
2.3
Forward
19.2
More Details
62
P/E
P/E
Price to Earnings
62
vs History
22
vs Industry
15
Median 3Y
48.1
Median 5Y
52.4
Industry
23.1
Forward
49.1
More Details
48.6
P/OCF
P/OCF
Price to OCF
48.6
vs History
31
vs Industry
13
Median 3Y
36
Median 5Y
36.4
Industry
14.2
More Details
49.9
P/FCFE
P/FCFE
Price to FCFE
49.9
vs History
31
vs Industry
19
Median 3Y
37.1
Median 5Y
38
Industry
20.1
More Details
11.3
P/B
P/B
Price to Book Value
11.3
vs History
20
vs Industry
13
Median 3Y
7
Median 5Y
7.1
Industry
2.2
More Details
19.3
EV/S
EV/S
Enterprise Value to Sales
19.3
vs History
27
vs Industry
13
Median 3Y
13.8
Median 5Y
14
Industry
2.4
Forward
17.8
More Details
21.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
21.5
vs History
27
vs Industry
20
Median 3Y
15.4
Median 5Y
15.8
Industry
5
More Details
46.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
46.4
vs History
38
vs Industry
13
Median 3Y
40.4
Median 5Y
42
Industry
12.7
Forward
34.6
More Details
49.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
49.5
vs History
38
vs Industry
17
Median 3Y
43.5
Median 5Y
44.7
Industry
17.1
Forward
35.8
More Details
44.7
EV/OCF
EV/OCF
Enterprise Value to OCF
44.7
vs History
31
vs Industry
17
Median 3Y
31.8
Median 5Y
32.2
Industry
14
More Details
46
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
46
vs History
31
vs Industry
19
Median 3Y
32.9
Median 5Y
33.5
Industry
18
More Details
32.2
EV/IC
EV/IC
Enterprise Value to IC
32.2
vs History
25
vs Industry
6
Median 3Y
20.7
Median 5Y
21.1
Industry
1.9
More Details

Multiples Across Competitors

DOCS Competitors Multiples
Doximity Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Doximity Inc
NYSE:DOCS
10.7B USD 20.9 62 46.4 49.5
US
Veeva Systems Inc
NYSE:VEEV
35.9B USD 13.7 54.6 45.7 49
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
26.7B AUD 160.4 322.2 225.5 225
US
Waystar Holding Corp
NASDAQ:WAY
6.3B USD 6.9 -120.4 24.5 68.2
JP
M3 Inc
TSE:2413
934B JPY 3.8 23.9 11.8 13.8
US
Inspire Medical Systems Inc
NYSE:INSP
5.4B USD 7.4 170.2 271.8 370.2
SE
Sectra AB
STO:SECT B
53.5B SEK 29.5 119.5 -71.4 -71.4
US
Vocera Communications Inc
F:V00
2.4B EUR 10.7 -294.8 239.5 3 835.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
16.2B CNY 5.1 45.1 32.4 33.2
US
Omnicell Inc
NASDAQ:OMCL
2.1B USD 2 -117.8 23.9 -69.2
P/E Multiple
Earnings Growth P/E to Growth
US
Doximity Inc
NYSE:DOCS
Average P/E: 106.3
62
78%
0.8
US
Veeva Systems Inc
NYSE:VEEV
54.6
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
322.2
131%
2.5
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -120.4 N/A N/A
JP
M3 Inc
TSE:2413
23.9
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
170.2
N/A N/A
SE
Sectra AB
STO:SECT B
119.5
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -294.8 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
45.1
142%
0.3
US
Omnicell Inc
NASDAQ:OMCL
Negative Multiple: -117.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Doximity Inc
NYSE:DOCS
Average EV/EBITDA: 94.3
46.4
92%
0.5
US
Veeva Systems Inc
NYSE:VEEV
45.7
221%
0.2
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225.5
130%
1.7
US
W
Waystar Holding Corp
NASDAQ:WAY
24.5
N/A N/A
JP
M3 Inc
TSE:2413
11.8
24%
0.5
US
Inspire Medical Systems Inc
NYSE:INSP
271.8
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
239.5
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
32.4
143%
0.2
US
Omnicell Inc
NASDAQ:OMCL
23.9
153%
0.2
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Doximity Inc
NYSE:DOCS
Average EV/EBIT: 520.8
49.5
102%
0.5
US
Veeva Systems Inc
NYSE:VEEV
49
239%
0.2
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
225
122%
1.8
US
W
Waystar Holding Corp
NASDAQ:WAY
68.2
N/A N/A
JP
M3 Inc
TSE:2413
13.8
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
370.2
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -71.4 N/A N/A
US
V
Vocera Communications Inc
F:V00
3 835.2
N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
33.2
123%
0.3
US
Omnicell Inc
NASDAQ:OMCL
Negative Multiple: -69.2 N/A N/A

See Also

Summary
DOCS intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOCS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOCS stock valuation using valuation multiples.
Wall Street Estimates
DOCS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOCS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.